Journal
MEDICINAL CHEMISTRY RESEARCH
Volume 31, Issue 6, Pages 833-850Publisher
SPRINGER BIRKHAUSER
DOI: 10.1007/s00044-022-02901-2
Keywords
Posaconazole; Antifungal activity; Triazoles; Synthesis; SAR study
Categories
Ask authors/readers for more resources
Posaconazole is a broad-spectrum oral antifungal drug with a complex structure. Its non-classical properties make it have antitrypanosomal, antileishmanial, and hedgehog signaling pathway inhibitory activities.
Posaconazole (PSZ, SCH 56592), is a new generation of orally active triazole antifungal agent with a tetrahydrofuran center, derived from itraconazole (ITZ). This drug has a broader spectrum of activity respect to the dioxolane-based triazoles. Structurally, PSZ molecule with four chiral centers and long side chain has a complicated structure. In this review, we describe general aspects of PSZ, including chemistry, pharmacological properties, mechanism of action, synthetic strategies, synthesis of key intermediates, structure-antifungal activity relationships, and the design of its prodrugs. Finally, the non-classical properties of PSZ including antitrypanosomal, antileishmanial and hedgehog (Hh) signaling pathway inhibitory activities will be discussed. By highlighting the information and experiences gained with PSZ, we can better move toward newer compounds of this generation. [GRAPHICS] .
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available